GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » Institutional Ownership

SLS BIO Co (XKRX:246250) Institutional Ownership : 0.00% (As of Jun. 20, 2024)


View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SLS BIO Co's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SLS BIO Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SLS BIO Co's Float Percentage Of Total Shares Outstanding is 0.00%.


SLS BIO Co Institutional Ownership Historical Data

The historical data trend for SLS BIO Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co Institutional Ownership Chart

SLS BIO Co Historical Data

The historical data trend for SLS BIO Co can be seen below:

2021-02-28 2021-03-31 2021-04-30 2021-05-31 2021-06-30 2021-07-31 2021-08-31 2021-09-30 2021-10-31 2021-11-30
Institutional Ownership 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.09 0.09 0.09

SLS BIO Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


SLS BIO Co (XKRX:246250) Business Description

Traded in Other Exchanges
N/A
Address
Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines